Ceftazidime 500mg powder for solution for injection vials

Valsts: Lielbritānija

Valoda: angļu

Klimata pārmaiņas: MHRA (Medicines & Healthcare Products Regulatory Agency)

Aktīvā sastāvdaļa:

Ceftazidime pentahydrate

Pieejams no:

Bowmed Ibisqus Ltd

ATĶ kods:

J01DD02

SNN (starptautisko nepatentēto nosaukumu):

Ceftazidime pentahydrate

Deva:

500mg

Zāļu forma:

Powder for solution for injection

Ievadīšanas:

Intravenous; Intramuscular

Klase:

No Controlled Drug Status

Receptes veids:

Valid as a prescribable product

Produktu pārskats:

BNF: 05010201; GTIN: 5060130130232

Lietošanas instrukcija

PACKAGE LEAFLET: INFORMATION FOR THE USER
CEFTAZIDIME 500 MG POWDER FOR SOLUTION FOR INJECTION
Ceftazidime
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS
MEDICINE BECAUSE IT CONTAINS IMPORTANT
INFORMATION FOR YOU.
•
Keep this leaflet. You may need to read it again.
• If you have any further questions, ask your doctor.
• If any of the side effects get serious, or if you notice any side
effects not listed in this leaflet, please tell
your doctor.
IN THIS LEAFLET
:
1. What Ceftazidime Injection is and what it is used for
2. Before you are given Ceftazidime Injection
3. How Ceftazidime Injection is given
4. Possible side effects
5. How to store Ceftazidime Injection
6. Further information
The name of your medicine is “Ceftazidime powder for solution for
injection” (referred to as
CEFTAZIDIME
INJECTION
throughout this leaflet).
1. WHAT CEFTAZIDIME INJECTION IS AND WHAT IT IS USED FOR
Ceftazidime is an antibiotic used in adults and children (including
newborn babies). It works by killing
bacteria that cause infections. It belongs to a group of medicines
called cephalosporins
_. _
CEFTAZIDIME IS USED TO TREAT SEVERE BACTERIAL INFECTIONS OF
:
• the lungs or chest
• the lungs and bronchi in patients suffering from cystic fibrosis
• the brain (meningitis)
• the ear
• the urinary tract
• the skin and soft tissues
• the abdomen and abdominal wall (peritonitis)
• the bones and joints.
Ceftazidime can also be used:
• to prevent infections during prostate surgery in men
• to treat patients with low white blood cell counts (neutropenia)
who have a fever due to a bacterial
infection.
2. WHAT YOU NEED TO KNOW BEFORE YOU ARE GIVEN CEFTAZIDIME INJECTION
YOU MUST NOT BE GIVEN CEFTAZIDIME INJECTION:
• IF YOU ARE ALLERGIC
(hypersensitive)
to
CEFTAZIDIME
or the other ingredients of this medicine (see section 6).
• if you have had a
SEVERE ALLERGIC REACTION
to any
OTHER ANTIBIOTIC
(penicillins, monobactams and
carbapenems) as you may also be allergic to Ceftazidime.
TELL YOUR DOCTOR BEFOR

Produkta apraksts

OBJECT 1
CEFTAZIDIME 500MG POWDER FOR
SOLUTION FOR INJECTION VIALS
Summary of Product Characteristics Updated 21-Apr-2022 | Bowmed
Ibisqus Limited
•
1. Name of the medicinal product
•
2. Qualitative and quantitative composition
•
3. Pharmaceutical form
•
4. Clinical particulars
•
4.1 Therapeutic indications
•
4.2 Posology and method of administration
•
4.3 Contraindications
•
4.4 Special warnings and precautions for use
•
4.5 Interaction with other medicinal products and other forms of
interaction
•
4.6 Fertility, pregnancy and lactation
•
4.7 Effects on ability to drive and use machines
•
4.8 Undesirable effects
•
4.9 Overdose
•
5. Pharmacological properties
•
5.1 Pharmacodynamic properties
•
5.2 Pharmacokinetic properties
•
5.3 Preclinical safety data
•
6. Pharmaceutical particulars
•
6.1 List of excipients
•
6.2 Incompatibilities
•
6.3 Shelf life
•
6.4 Special precautions for storage
•
6.5 Nature and contents of container
•
6.6 Special precautions for disposal and other handling
•
7. Marketing authorisation holder
•
8. Marketing authorisation number(s)
•
9. Date of first authorisation/renewal of the authorisation
•
10. Date of revision of the text
1. Name of the medicinal product
Ceftazidime 500mg Powder for Solution for Injection
2. Qualitative and quantitative composition
Each vial contains 500mg Ceftazidime (as pentahydrate)
Also contains sodium carbonate anhydrous (equivalent to 26mg sodium)
For a full list of excipients, see section 6.1.
3. Pharmaceutical form
Powder for solution for injection
A white to cream-coloured powder.
4. Clinical particulars
4.1 Therapeutic indications
Ceftazidime is indicated for the treatment of the infections listed
below in adults and children including
neonates (from birth).
• Nosocomial pneumonia
• Broncho-pulmonary infections in cystic fibrosis
• Bacterial meningitis
• Chronic suppurative otitis media
• Malignant otitis externa
• Complicated urinary tract infections
• Complicated skin and soft tissue inf